Evidence map›Paper›PMID 35136039›Full record

ArticleNature communications2022

Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong.

Haogao Gu, Ruopeng Xie, Dillon C Adam, Joseph L-H Tsui, Daniel K Chu, Lydia D J Chang, Sammi S Y Cheuk, Shreya Gurung, Pavithra Krishnan, Daisy Y M Ng and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. HLA-B*15:01-positive severe COVID-19 patients lack CD8Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The origins of COVID-19 pandemic: A brief overview.Transboundary and emerging diseases · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Haogao Gu *School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0002-7541-4262
Ruopeng Xie *School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Dillon C Adam *School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Joseph L-H Tsui *School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Daniel K Chu *School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Lydia D J ChangSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Sammi S Y CheukSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Shreya GurungSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Pavithra KrishnanSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Daisy Y M NgSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Gigi Y Z LiuSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Carrie K C WanSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Samuel S M ChengSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Kimberly M EdwardsSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0003-0944-3118
Kathy S M LeungSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0003-4777-388X
Joseph T WuSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Dominic N C TsangCentre for Health Protection, Department of Health, The Government of Hong Kong Special Administrative Region, Hong Kong, China.
Gabriel M LeungSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0002-2503-6283
Benjamin J CowlingSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0002-6297-7154
Malik PeirisSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0001-8217-5995
Tommy T Y LamSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0002-9769-1527
Vijaykrishna DhanasekaranSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. veej@hku.hk.ORCID http://orcid.org/0000-0003-3293-6279
Leo L M PoonSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. llmpoon@hku.hk.ORCID http://orcid.org/0000-0002-9101-7953

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00016 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WEBBY, RICHARD · 2021 to 2025
$91.4M
Emerging infections: surveillance, epidemiology and pathogenesisU01AI151810 · NIAID · WASHINGTON UNIVERSITY · PI Adrianus CM Boon, DAVID WANG · 2020 to 2026
$10.0M
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF) COVID190118NIAID NIH HHS 75N93021C00016NIAID NIH HHS HHSN272201400006CNIAID NIH HHS U01 AI151810Research Grants Council, University Grants Committee (RGC, UGC) C7123-20G
6 · The paper itself

Abstract

Hong Kong employed a strategy of intermittent public health and social measures alongside increasingly stringent travel regulations to eliminate domestic SARS-CoV-2 transmission. By analyzing 1899 genome sequences (>18% of confirmed cases) from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible for 90% of locally-acquired cases. Community outbreaks were caused by novel introductions rather than a resurgence of circulating strains. Thus, local outbreak prevention requires strong border control and community surveillance, especially during periods of less stringent social restriction. Non-adherence to prolonged preventative measures may explain sustained local transmission observed during wave four in late 2020 and early 2021. We also found that, due to a tight transmission bottleneck, transmission of low-frequency single nucleotide variants between hosts is rare.

Indexed as

COVID-19GenomicsHong KongHumansPublic HealthSARS-CoV-2Travel

Identifiers

PMID35136039
PMCPMC8825829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.